These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2524315)

  • 1. [Treatment with deflazacort associated with a thyrostatic therapy in a case of juvenile Basedow's ophthalmopathy. Clinical and hematochemical evaluation of therapeutic results].
    Letizia C; Sellini M; Di Palma L
    Clin Ter; 1989 Feb; 128(4):261-5. PubMed ID: 2524315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of Graves' disease: effects of the administration of L-thyroxine associated with methimazole as a single daily dose.
    Perozim LM; Lima N; Knobel M; Cavaliere H; Medeiros-Neto G
    Eur J Med; 1993 Feb; 2(2):70-4. PubMed ID: 8258020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Thyroid hormone dynamics during the thyrostatic treatment of Basedow's disease].
    Vŭrbanov V; Zakharieva B; Manolov D; Zhelev N
    Vutr Boles; 1990; 29(1):68-73. PubMed ID: 1697716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dynamic thyroid hormone levels during the thyrostatic treatment of Basedow's disease].
    Vŭrbanov V; Zakharieva B; Manolov D
    Vutr Boles; 1988; 27(4):15-8. PubMed ID: 2463711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The balance shift in Th1/Th2 related IL-12/IL-5 cytokines in Graves' disease during methimazole therapy.
    Molnár I
    Autoimmunity; 2007 Feb; 40(1):31-7. PubMed ID: 17364495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of thyrostatic therapy of hyperthyroidism in patients with Basedow's disease and disseminated autonomy].
    Meng W; Meng S; Hampel R; Ventz M; Männchen E; Weber W; Streckenbach B
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(6):337-40. PubMed ID: 3129277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of fasciitis associated with Basedow's disease and polymyositis].
    Mihori A; Morio T; Nakayama M; Ono S; Shimizu N
    Rinsho Shinkeigaku; 1998 Jan; 38(1):27-31. PubMed ID: 9597906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in TSH receptor antibody levels (TRAb) as markers of effectiveness of various therapies in Graves-Basedow's disease.
    Bojarska-Szmygin A; Janicki K; Pietura R; Janicka L
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(1):248-53. PubMed ID: 15314994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical results of anti-inflammatory therapy in Graves' ophthalmopathy and association with thyroidal autoantibodies.
    Eckstein AK; Plicht M; Lax H; Hirche H; Quadbeck B; Mann K; Steuhl KP; Esser J; Morgenthaler NG
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):612-8. PubMed ID: 15521965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
    He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease.
    Akin F; Yaylali GF; Bastemir M; Yapar B
    Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibodies against TSH receptors (TRAb) as indicators in prognosing the effectiveness of Tiamazol therapy for Grave's Disease].
    Bojarska-Szmygin A; Ciechanek R
    Wiad Lek; 2003; 56(7-8):303-7. PubMed ID: 14969154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Basedow's disease. Individual therapy of is great significance].
    Hörmann R
    MMW Fortschr Med; 2005 Sep; 147(35-36):47. PubMed ID: 16180573
    [No Abstract]   [Full Text] [Related]  

  • 14. [Surgical treatment of Basedow's disease: our experience with 424 operations].
    Candela G; Varriale S; Manetta F; Di Libero L; Maschio A; Pizza A; Napolitano S; Santini L
    Chir Ital; 2007; 59(5):707-11. PubMed ID: 18019644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of an artificial neural network to predict Graves' disease outcome within 2 years of drug withdrawal.
    Orunesu E; Bagnasco M; Salmaso C; Altrinetti V; Bernasconi D; Del Monte P; Pesce G; Marugo M; Mela GS
    Eur J Clin Invest; 2004 Mar; 34(3):210-7. PubMed ID: 15025680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Spontaneous hypothyroidism in 4 patients with Graves-Basedow disease].
    González-González A; Recio Cordova JM; Aznar Ondoño I; Del Monte Jarabo Bueno M
    Endocrinol Nutr; 2009 May; 56(5):273-6. PubMed ID: 19627750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Iodine-induced hyperthyroidism (iodine-induced Basedow's disease): a current disease picture].
    Henzen C; Buess M; Brander L
    Schweiz Med Wochenschr; 1999 May; 129(17):658-64. PubMed ID: 10407936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Two cases of systemic lupus erythematosus associated with fatty liver and Basedow's disease].
    Itateyama E; Dohmen K; Nishizaka H; Shibuya T; Nakamura H; Arase K; Yokogawa Y; Asayama R; Ishibashi H
    Fukuoka Igaku Zasshi; 1994 Mar; 85(3):101-7. PubMed ID: 8175101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. No association between Fas A/G polymorphism and therapeutic effects induced by methimazole treatment for Graves' disease in Northern Chinese.
    Li P; Li Q; Chen L; Sun Y; Zhang J
    Pharmazie; 2008 Oct; 63(10):748-50. PubMed ID: 18972838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subtotal thyroidectomy as a superior therapeutic principle in the treatment of endocrine ophthalmopathy: a comparison with retrobulbar irradiation and thyrostatic therapy alone].
    Grussendorf M; Horster FA; Inanc Y; Goretzki PE; Röher HD; Krüskemper HL
    Wien Klin Wochenschr; 1988 May; 100(11):355-7. PubMed ID: 3407195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.